United Kingdom · Series C startup
Funding summaryUpdated 26 Oct 2026
$239Mraised across 5 rounds since 2021, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Shares issued, filed with Companies House (SH01); no report of this raise yet and 1 other
Source recorded
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
bit.bio filed 3 raises, $159M in all. Filings say how much was sold and to how many investors; they never name the investors.
From bit.bio's own website: 1 founder, 11 on the team.
AdvisersAltos LabsAnil DhawanKaty RezvaniLoïc VincentMarius Wernig
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tengxun Touzi
ARCH Venture Partners
Foresite Capital
BlueYard Capital
Global Brain Corporation
In-Q-Tel
Puhua Capital
ZAKA VCMissing a round, or an investor who was in one? Tell us.
bit.bio's investors include Tengxun Touzi, ARCH Venture Partners, Foresite Capital, BlueYard Capital and Global Brain Corporation, and 3 more on record.
bit.bio has raised $239M across 5 rounds since 2021.
bit.bio's most recent round was a Series C of $19M in Apr 2026.
bit.bio's largest round on record is $103M (Series B), in Sept 2021.
bit.bio's first round on record, in Dec 2024, was backed by Tengxun Touzi, ARCH Venture Partners and Foresite Capital and 1 others.
bit.bio's latest named round is a Series C, in Apr 2026.
bit.bio is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
